In the context of the 32nd BioCity Symposium (24-25 August 2023) the nineteenth Elias Tillandz prize will be awarded for the best scientific paper published in 2022 in Turku.
What is BioCity Turku and what do they do?
What are BioCity Turku Research Programs?
Could I find ideas for new collaborative projects?
Frontiers of Science Seminar program is ready for spring 2023. All seminars are on-site only at 12:00 in BioCity, Presidentti auditorium, if not stated otherwise. Coffee and sandwich is served before each seminar.
Turku can, for a good reason, be called the imaging capital of Finland and even the entire Europe. The city is home to both the headquarters of the Euro-BioImaging research infrastructure and the national Turku PET Centre, one of the continent’s most important medical imaging centres.
Researchers from the Turku PET Centre, Finland, have observed that the length of daylight hours impacts opioid receptor levels in brown fat. When daylight hours shorten, the receptor activity levels elevate. A similar phenomenon also takes place in the brain. Both phenomena help people and animals in the adaptation to seasonal changes.
There are approximately 40 trillion cells in the human body and every one of them needs oxygen to survive. If the oxygen level drops, the cells must be able to sense the change and adapt to it. Sir Peter Ratcliffe discovered how this adaptation occurs. The discovery earned Ratcliffe and his associates the Nobel Prize in Physiology or Medicine in 2019. Ratcliffe visited the University of Turku 25 August.
The theme of this year’s BioCity Symposium, immunology, has sparked great interest. Over 400 people have registered for the Symposium that is organised on 25–26 August. The keynote speaker is Sir Peter Ratcliffe, the Nobel Prize Laureate in medicine 2019.
Registration to BioCity Symposium is open until 11 August 2022. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged together with InFLAMES Flagship with title Solution is in Immunity.
This year BioCity Student Symposium titled Students are the Solution is arranged on-site by PhD researchers from The University of Turku and Abo Akademi University together with BioCity Turku and InFLAMES Flagship in Cave theatre - Visitor and Innovation Centre Joki, 24th August 2022.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.